RRM2B and adenocarcinoma: There were more p53R2-positive cases in nonsquamous than in squamous NSCLC and this is concordant with a previous study [12] and with the evidence that patients with adenocarcinoma have a worse prognosis than patients with squamous cell carcinoma.